Rani V Ramachandran, MD
Infectious Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 9 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ramachandran’s office at (408) 294-2399 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A48819 · Current
Licensed to practise in California · since 1990 · expires 2028-06-30 · University of Madras, Madras Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$184,548
Medicare paid this office $184,548 for 309 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 290 | $141,875 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 232 | $39,631 | $154 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,351 | $104 |
Who their Medicare patients are
309 Original Medicare patients in 2024. Average age 79 · Under 65 12% · 85 and older 36% · Women 56% · Also on Medicaid 86% · Health risk score 3.04. Above the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 66% · Chronic kidney disease 51% · Heart failure 46% · Coronary heart disease 45% · Dementia 41% · Atrial fibrillation 37% · COPD 31% · Depression 26% · Stroke 17% · Cancer 14%.
The office billed $333,835, Medicare allowed $232,047 and paid $184,548; for 1,630 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 309 | 1,630 | 79 | 3.04 | $333,835 | $184,548 |
| 2023 | 306 | 1,599 | 80 | 2.96 | $311,515 | $180,563 |
| 2022 | 380 | 2,387 | 78 | 3.21 | $471,025 | $255,791 |
| 2021 | 400 | 2,544 | 77 | 3.39 | $503,470 | $276,599 |
| 2020 | 420 | 3,159 | 78 | 3.55 | $591,354 | $343,030 |
| 2019 | 533 | 2,980 | 79 | 3.67 | $437,280 | $319,911 |
| 2018 | 536 | 3,062 | 77 | 3.62 | $450,789 | $329,325 |
| 2017 | 559 | 3,036 | 77 | 3.45 | $443,524 | $429,392 |
| 2016 | 499 | 2,616 | 77 | 3.48 | $461,508 | $277,889 |
| 2015 | 525 | 2,930 | 78 | 3.21 | $419,835 | $307,551 |
| 2014 | 523 | 4,382 | 77 | 3.00 | $433,836 | $309,418 |
| 2013 | 638 | 3,531 | 77 | 3.01 | $487,995 | $358,032 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 294 | $143,104 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 193 | $32,396 | $156 |
| Hospital discharge day management, more than 30 minutes | 21 | $2,120 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,568 | $71 |
2022: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 359 | $187,016 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 308 | $64,268 | $181 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,874 | $99 |
2021: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 374 | $200,825 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 320 | $69,537 | $183 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,332 | $95 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 374 | $250,425 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 323 | $77,188 | $188 |
| Hospital discharge day management, more than 30 minutes | 49 | $4,862 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $3,516 | $68 |
| Return visit (30+ min) | 16 | $2,200 | $105 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 12 | $1,913 | $74 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 456 | $211,508 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 378 | $83,476 | $183 |
| Hospital discharge day management, more than 30 minutes | 74 | $7,433 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $6,597 | $66 |
| Return visit (30+ min) | 30 | $3,734 | $101 |
| Long return visit (40+ min) | 16 | $2,217 | $139 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 17 | $2,039 | $85 |
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 475 | $217,978 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 395 | $88,316 | $181 |
| Return visit (30+ min) | 43 | $6,012 | $100 |
| Hospital discharge day management, more than 30 minutes | 52 | $5,234 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $4,837 | $65 |
| Long return visit (40+ min) | 23 | $3,002 | $131 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 500 | $279,095 | $122 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 400 | $114,549 | $237 |
| Hospital discharge day management, more than 30 minutes | 122 | $16,715 | $129 |
| Return visit (30+ min) | 35 | $7,430 | $130 |
| Long return visit (40+ min) | 23 | $4,133 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,706 | $85 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 422 | $172,076 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 321 | $71,655 | $180 |
| Return visit (30+ min) | 51 | $9,816 | $97 |
| Hospital discharge day management, more than 30 minutes | 78 | $7,974 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $4,180 | $64 |
| Long return visit (40+ min) | 27 | $4,039 | $135 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 23 | $2,499 | $83 |
2015: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 464 | $198,480 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 337 | $75,425 | $177 |
| Hospital discharge day management, more than 30 minutes | 106 | $10,418 | $96 |
| Return visit (30+ min) | 59 | $10,140 | $98 |
| Long return visit (40+ min) | 16 | $2,550 | $127 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 11 | $2,294 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,916 | $64 |
2014: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 461 | $199,847 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 324 | $67,213 | $178 |
| Hospital discharge day management, more than 30 minutes | 125 | $13,033 | $97 |
| Return visit (30+ min) | 38 | $7,992 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $3,587 | $64 |
| Long return visit (40+ min) | 11 | $1,600 | $133 |
2013: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 531 | $211,309 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 398 | $87,937 | $175 |
| Hospital discharge day management, more than 30 minutes | 133 | $14,893 | $94 |
| Return visit (30+ min) | 84 | $14,539 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 117 | $10,360 | $62 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 15 | $5,432 | $79 |
| New patient visit (45+ min) | 21 | $3,072 | $146 |
| Long return visit (40+ min) | 13 | $1,731 | $133 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $506 | $34 |
Medicaid work
$11,505 in 2024
Medicaid paid $11,505 for 732 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 576 | $8,213 |
| 1ST HOSP IP/OBS HIGH 75 | 156 | $3,292 |
| 2024 | 732 | 2 | 30 | $11,505 |
| 2023 | 1,029 | 2 | 40 | $12,812 |
| 2022 | 1,345 | 2 | 42 | $14,223 |
| 2021 | 1,883 | 2 | 52 | $19,578 |
| 2020 | 1,768 | 2 | 45 | $8,139 |
| 2019 | 731 | 2 | 30 | $6,479 |
| 2018 | 494 | 2 | 25 | $6,515 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 811 | $9,767 |
| 1ST HOSP IP/OBS HIGH 75 | 218 | $3,044 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,046 | $9,625 |
| 1ST HOSP IP/OBS HIGH 75 | 299 | $4,599 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,568 | $15,359 |
| 1ST HOSP IP/OBS HIGH 75 | 315 | $4,218 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 1,526 | $6,773 |
| 1ST HOSP IP/OBS HIGH 75 | 242 | $1,365 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 632 | $4,670 |
| 1ST HOSP IP/OBS HIGH 75 | 99 | $1,809 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 390 | $3,919 |
| 1ST HOSP IP/OBS HIGH 75 | 104 | $2,595 |
Drugs they prescribed that Part D paid
$9,026
Pharmacies billed $9,026 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
308 generic and fewer than 11 brand-name prescriptions · $9,026 in drug cost · 43 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levetiracetam | 35 | $508 | $15 |
| Tamsulosin | 36 | $356 | $10 |
| Glimepiride | 35 | $297 | $8 |
| Metformin | 35 | $254 | $7 |
| Terazosin | 35 | $241 | $7 |
See all 6 drugs
| Levetiracetam | 35 | $508 | $15 |
| Tamsulosin | 36 | $356 | $10 |
| Glimepiride | 35 | $297 | $8 |
| Metformin | 35 | $254 | $7 |
| Terazosin | 35 | $241 | $7 |
| Simvastatin | 35 | $228 | $7 |
Year by year
| 2024 | 313 | 48 | None | None | $9,026 |
| 2023 | 190 | 34 | 0% (0) | None | $9,783 |
| 2022 | 142 | 30 | None | None | $16,763 |
| 2021 | 176 | 32 | None | 6% | $44,785 |
| 2020 | 327 | 53 | None | None | $21,303 |
| 2019 | 402 | 70 | 3% (11) | 7% | $19,078 |
| 2018 | 660 | 103 | 3% (22) | 10% | $52,928 |
| 2017 | 750 | 109 | 3% (23) | 9% | $40,597 |
| 2016 | 785 | 104 | 5% (37) | 14% | $51,818 |
| 2015 | 1,039 | 101 | 4% (43) | 24% | $86,761 |
| 2014 | 1,142 | 82 | 10% (108) | None | $90,847 |
| 2013 | 1,274 | 103 | 8% (104) | 25% | $90,754 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Levetiracetam | 18 | $520 | $29 |
| Tamsulosin | 20 | $323 | $16 |
| Glimepiride | 18 | $225 | $12 |
| Metformin | 18 | $175 | $10 |
| Terazosin | 18 | $156 | $9 |
| Simvastatin | 18 | $139 | $8 |
2022: 7 drugs
| Caspofungin Acetate | 13 | $7,272 | $559 |
| Levetiracetam | 12 | $485 | $40 |
| Tamsulosin | 12 | $277 | $23 |
| Glimepiride | 12 | $198 | $17 |
| Metformin | 12 | $141 | $12 |
| Terazosin | 12 | $122 | $10 |
| Simvastatin | 12 | $105 | $9 |
2021: 8 drugs
| Rifampin | 16 | $764 | $48 |
| Levetiracetam | 12 | $485 | $40 |
| Tamsulosin | 12 | $277 | $23 |
| Glimepiride | 12 | $198 | $17 |
| Isoniazid | 12 | $136 | $11 |
| Metformin | 13 | $135 | $10 |
| Terazosin | 12 | $122 | $10 |
| Simvastatin | 12 | $105 | $9 |
2020: 11 drugs
| Vancomycin | 15 | $1,852 | $123 |
| Rifampin | 25 | $1,774 | $71 |
| Ethambutol | 15 | $883 | $59 |
| Levetiracetam | 12 | $486 | $40 |
| Tamsulosin | 13 | $285 | $22 |
| Azithromycin | 11 | $274 | $25 |
| Glimepiride | 12 | $198 | $17 |
| Terazosin | 12 | $122 | $10 |
| Metformin | 16 | $120 | $8 |
| Isoniazid | 21 | $108 | $5 |
| Simvastatin | 12 | $105 | $9 |
2019: 17 drugs
| Xarelto | 14 | $2,360 | $169 |
| Pyrazinamide | 11 | $1,609 | $146 |
| Oxybutynin Chloride Er | 39 | $1,095 | $28 |
| Rifampin | 14 | $721 | $51 |
| Ethambutol | 13 | $582 | $45 |
| Levetiracetam | 12 | $485 | $40 |
| Rosuvastatin | 11 | $313 | $28 |
| Tamsulosin | 13 | $284 | $22 |
| Cefdinir | 13 | $233 | $18 |
| Hydrocodone-Acetaminophen | 11 | $216 | $20 |
| Ciprofloxacin | 17 | $216 | $13 |
| Olanzapine | 12 | $207 | $17 |
| Glimepiride | 12 | $198 | $17 |
| Metformin | 19 | $173 | $9 |
| Terazosin | 12 | $122 | $10 |
| Simvastatin | 12 | $105 | $9 |
| Isoniazid | 14 | $98 | $7 |
2018: 28 drugs
| Januvia | 13 | $6,057 | $466 |
| Xarelto | 16 | $2,491 | $156 |
| Oxybutynin Chloride Er | 29 | $977 | $34 |
| Levetiracetam | 24 | $767 | $32 |
| Rosuvastatin | 14 | $614 | $44 |
| Hydrocodone-Acetaminophen | 21 | $517 | $25 |
| Baclofen | 12 | $513 | $43 |
| Dicyclomine | 25 | $491 | $20 |
| Haloperidol | 15 | $398 | $27 |
| Divalproex | 12 | $396 | $33 |
| Cefdinir | 12 | $339 | $28 |
| Tamsulosin | 13 | $284 | $22 |
| Atorvastatin | 11 | $240 | $22 |
| Gabapentin | 13 | $231 | $18 |
| Benazepril | 31 | $230 | $7 |
| Donepezil | 11 | $216 | $20 |
| Olanzapine | 12 | $215 | $18 |
| Mirtazapine | 11 | $214 | $19 |
| Glimepiride | 12 | $198 | $17 |
| Metformin | 19 | $174 | $9 |
| Amlodipine Besylate | 17 | $149 | $9 |
| Citalopram Hbr | 12 | $132 | $11 |
| Terazosin | 13 | $127 | $10 |
| Ciprofloxacin | 16 | $123 | $8 |
| Simvastatin | 12 | $105 | $9 |
| Isoniazid | 13 | $95 | $7 |
| Prednisone | 14 | $72 | $5 |
| Furosemide | 16 | $61 | $4 |
2017: 33 drugs
| Januvia | 12 | $5,232 | $436 |
| Namenda Xr | 12 | $5,219 | $435 |
| Ethambutol | 17 | $1,260 | $74 |
| Oxybutynin Chloride Er | 23 | $838 | $36 |
| Levetiracetam | 27 | $773 | $29 |
| Rifampin | 13 | $771 | $59 |
| Rosuvastatin | 16 | $641 | $40 |
| Baclofen | 12 | $522 | $44 |
| Olanzapine | 11 | $467 | $42 |
| Haloperidol | 25 | $457 | $18 |
| Doxycycline Hyclate | 17 | $410 | $24 |
| Dicyclomine | 23 | $372 | $16 |
| Tamsulosin | 16 | $339 | $21 |
| Benztropine Mesylate | 12 | $323 | $27 |
| Cefdinir | 13 | $285 | $22 |
| Gabapentin | 14 | $237 | $17 |
| Mirtazapine | 13 | $234 | $18 |
| Donepezil | 12 | $232 | $19 |
| Glimepiride | 15 | $227 | $15 |
| Alendronate | 11 | $198 | $18 |
| Terazosin | 25 | $195 | $8 |
| Hydrocodone-Acetaminophen | 20 | $194 | $10 |
| Benazepril | 23 | $183 | $8 |
| Metformin | 16 | $177 | $11 |
| Prednisone | 24 | $147 | $6 |
| Amlodipine Besylate | 17 | $144 | $8 |
| Ciprofloxacin | 13 | $137 | $11 |
| Isoniazid | 23 | $128 | $6 |
| Citalopram Hbr | 11 | $122 | $11 |
| Simvastatin | 14 | $111 | $8 |
| Pioglitazone | 12 | $52 | $4 |
| Diazepam | 12 | $38 | $3 |
| Furosemide | 14 | $35 | $2 |
2016: 34 drugs
| Namenda Xr | 15 | $4,717 | $314 |
| Januvia | 12 | $4,667 | $389 |
| Levofloxacin | 30 | $1,329 | $44 |
| Levetiracetam | 32 | $1,266 | $40 |
| Rifampin | 15 | $814 | $54 |
| Ethambutol | 13 | $765 | $59 |
| Hydrocodone-Acetaminophen | 34 | $706 | $21 |
| Baclofen | 12 | $658 | $55 |
| Amitriptyline | 12 | $593 | $49 |
| Tamsulosin | 12 | $437 | $36 |
| Gabapentin | 14 | $397 | $28 |
| Oxybutynin Chloride Er | 12 | $370 | $31 |
| Simvastatin | 13 | $328 | $25 |
| Citalopram Hbr | 15 | $327 | $22 |
| Amlodipine Besylate | 19 | $265 | $14 |
| Atorvastatin | 12 | $264 | $22 |
| Benazepril | 27 | $261 | $10 |
| Metformin | 18 | $259 | $14 |
| Alendronate | 22 | $250 | $11 |
| Haloperidol | 24 | $232 | $10 |
| Terazosin | 18 | $230 | $13 |
| Mirtazapine | 13 | $228 | $18 |
| Glimepiride | 19 | $227 | $12 |
| Losartan | 11 | $224 | $20 |
| Donepezil | 13 | $215 | $17 |
| Dicyclomine | 21 | $204 | $10 |
| Polyethylene Glycol 3350 | 14 | $202 | $14 |
| Isoniazid | 27 | $166 | $6 |
| Cephalexin | 18 | $159 | $9 |
| Benztropine Mesylate | 12 | $136 | $11 |
| Lisinopril | 11 | $123 | $11 |
| Prednisone | 12 | $60 | $5 |
| Pioglitazone | 12 | $45 | $4 |
| Diazepam | 12 | $44 | $4 |
2015: 45 drugs
| Voriconazole | 13 | $9,163 | $705 |
| Invanz | 16 | $7,163 | $448 |
| Xarelto | 23 | $3,903 | $170 |
| Januvia | 17 | $3,571 | $210 |
| Namenda Xr | 14 | $2,297 | $164 |
| Namenda | 13 | $2,189 | $168 |
| Levofloxacin | 44 | $1,798 | $41 |
| Pyrazinamide | 11 | $1,524 | $139 |
| Rifampin | 15 | $1,349 | $90 |
| Ethambutol | 14 | $1,025 | $73 |
| Oxycodone-Acetaminophen | 17 | $905 | $53 |
| Ceftriaxone | 16 | $882 | $55 |
| Oxybutynin Chloride Er | 21 | $626 | $30 |
| Hydrocodone-Acetaminophen | 25 | $590 | $24 |
| Amitriptyline | 12 | $589 | $49 |
| Levetiracetam | 25 | $491 | $20 |
| Atorvastatin | 23 | $476 | $21 |
| Levetiracetam Er | 17 | $397 | $23 |
| Polyethylene Glycol 3350 | 20 | $352 | $18 |
| Baclofen | 20 | $351 | $18 |
| Haloperidol | 12 | $338 | $28 |
| Amlodipine Besylate | 53 | $303 | $6 |
| Tamsulosin | 13 | $266 | $20 |
| Gabapentin | 24 | $258 | $11 |
| Alprazolam | 27 | $231 | $9 |
| Alendronate | 19 | $218 | $11 |
| Dicyclomine | 21 | $213 | $10 |
| Glimepiride | 13 | $208 | $16 |
| Metoprolol | 12 | $203 | $17 |
| Paroxetine | 16 | $197 | $12 |
| Mirtazapine | 14 | $196 | $14 |
| Metformin | 26 | $196 | $8 |
| Citalopram Hbr | 27 | $176 | $7 |
| Benztropine Mesylate | 14 | $139 | $10 |
| Benazepril | 19 | $138 | $7 |
| Losartan | 14 | $127 | $9 |
| Donepezil | 11 | $126 | $11 |
| Simvastatin | 15 | $110 | $7 |
| Terazosin | 12 | $110 | $9 |
| Carbidopa-Levodopa | 13 | $110 | $8 |
| Carvedilol | 13 | $76 | $6 |
| Isoniazid | 13 | $75 | $6 |
| Cephalexin | 15 | $68 | $5 |
| Furosemide | 16 | $60 | $4 |
| Diazepam | 13 | $52 | $4 |
2014: 38 drugs
| Voriconazole | 13 | $20,172 | $1,552 |
| Namenda | 27 | $4,275 | $158 |
| Xarelto | 22 | $2,988 | $136 |
| Hydrocodone-Acetaminophen | 76 | $2,892 | $38 |
| Oxycodone-Acetaminophen | 29 | $2,313 | $80 |
| Crestor | 11 | $2,064 | $188 |
| Oxybutynin Chloride Er | 24 | $842 | $35 |
| Levofloxacin | 16 | $593 | $37 |
| Levetiracetam | 29 | $533 | $18 |
| Atorvastatin | 25 | $517 | $21 |
| Amitriptyline | 12 | $466 | $39 |
| Amlodipine Besylate | 73 | $404 | $6 |
| Tamsulosin | 14 | $294 | $21 |
| Alendronate | 25 | $253 | $10 |
| Losartan | 19 | $251 | $13 |
| Haloperidol | 15 | $250 | $17 |
| Gabapentin | 27 | $239 | $9 |
| Paroxetine | 16 | $230 | $14 |
| Alprazolam | 31 | $226 | $7 |
| Metoprolol | 21 | $220 | $10 |
| Clopidogrel | 16 | $208 | $13 |
| Carbidopa-Levodopa | 17 | $207 | $12 |
| Polyethylene Glycol 3350 | 16 | $202 | $13 |
| Famotidine | 26 | $193 | $7 |
| Metformin | 23 | $187 | $8 |
| Potassium Chloride | 14 | $178 | $13 |
| Benazepril | 18 | $162 | $9 |
| Simvastatin | 22 | $161 | $7 |
| Donepezil | 13 | $148 | $11 |
| Cephalexin | 15 | $140 | $9 |
| Glimepiride | 18 | $129 | $7 |
| Risperidone | 11 | $116 | $11 |
| Carvedilol | 15 | $101 | $7 |
| Dicyclomine | 12 | $87 | $7 |
| Citalopram Hbr | 15 | $84 | $6 |
| Isoniazid | 14 | $77 | $6 |
| Diazepam | 15 | $32 | $2 |
| Furosemide | 13 | $30 | $2 |
2013: 42 drugs
| Namenda | 38 | $5,635 | $148 |
| Piperacillin-Tazobactam | 18 | $5,512 | $306 |
| Vancomycin | 12 | $2,705 | $225 |
| Vesicare | 12 | $2,617 | $218 |
| Hydrocodone-Acetaminophen | 67 | $973 | $15 |
| Oxycodone Hcl-Acetaminophen | 11 | $919 | $84 |
| Donepezil | 18 | $893 | $50 |
| Oxycodone-Acetaminophen | 24 | $845 | $35 |
| Levofloxacin | 35 | $783 | $22 |
| Oxybutynin Chloride Er | 20 | $775 | $39 |
| Atorvastatin | 18 | $673 | $37 |
| Amlodipine Besylate | 75 | $573 | $8 |
| Levetiracetam | 33 | $569 | $17 |
| Megestrol Acetate | 12 | $536 | $45 |
| Losartan | 16 | $523 | $33 |
| Haloperidol | 13 | $487 | $37 |
| Keppra Xr | 22 | $435 | $20 |
| Tamsulosin | 17 | $394 | $23 |
| Gabapentin | 24 | $339 | $14 |
| Polyethylene Glycol 3350 | 20 | $333 | $17 |
| Metformin | 31 | $275 | $9 |
| Azithromycin | 12 | $254 | $21 |
| Paroxetine | 14 | $253 | $18 |
| Alendronate | 25 | $247 | $10 |
| Carvedilol | 20 | $233 | $12 |
| Pantoprazole | 15 | $232 | $15 |
| Carbidopa-Levodopa | 13 | $229 | $18 |
| Simvastatin | 28 | $228 | $8 |
| Warfarin | 28 | $206 | $7 |
| Famotidine | 28 | $205 | $7 |
| Glimepiride | 32 | $198 | $6 |
| Zolpidem | 24 | $195 | $8 |
| Pravastatin | 11 | $191 | $17 |
| Benazepril | 12 | $184 | $15 |
| Metoprolol | 15 | $171 | $11 |
| Alprazolam | 23 | $132 | $6 |
| Nortriptyline | 12 | $127 | $11 |
| Lisinopril | 12 | $112 | $9 |
| Glyburide | 11 | $111 | $10 |
| Citalopram Hbr | 11 | $93 | $8 |
| Baclofen | 13 | $72 | $6 |
| Diazepam | 16 | $41 | $3 |
Money from drug and device companies
$42 in 2024
| 2024 | 1 | 2 | None | $42 |
| 2023 | 1 | 1 | None | $41 |
| 2022 | 1 | 1 | None | $116 |
| 2020 | 1 | 1 | None | $85 |
| 2019 | 2 | 3 | None | $280 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Insmed | Arikayce | $42 | 2 payments
|
See all 2 published payments
| Insmed | Meals · 2024-06-04 | Arikayce | $13 |
| Insmed | Meals · 2024-04-09 | Arikayce | $28 |
See earlier years (2023, 2022, 2020, 2019)
2023: $41
| Insmed | Arikayce | $41 | 1 payment
|
2022: $116
| Insmed | Arikayce | $116 | 1 payment
|
2020: $85
| Janssen Pharmaceuticals | Xarelto | $85 | 1 payment
|
2019: $280
| Amarin Pharma | Vascepa | $259 | 2 payments
|
| Paratek Pharmaceuticals | Nuzyra | $21 | 1 payment
|
Professional record
- NPI
- 1881621324
- Licence
- CA A48819California A48819: Current · expires 2028-06-30
- Gender
- Female
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A488191
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 2081 Forest Ave Ste 1, San Jose, CA, 95128
- NPI first listed
- 2006-06-28
- NPI last updated
- 2024-04-19
- NPI record certified
- 2024-04-19
This is when the NPI record was last certified, not a medical board exam.